UB Paderborn / Katalog / Suche / in CDI

COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva

Journal of clinical microbiology, 2020-12, Vol.59 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States

Clinical infectious diseases, 2021-03, Vol.72 (5), p.e154-e157

2021

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System

Frontiers in public health, 2021-07, Vol.9, p.695807-695807

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients

Clinical infectious diseases, 2022-03, Vol.74 (4), p.715-718

2022

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients

Microbiology spectrum, 2022-04, Vol.10 (2), p.e0021122-e0021122

2022

Link zum Volltext

Verfügbarkeit prüfen

Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic

Clinical infectious diseases, 2022-08, Vol.75 (Suppl 1), p.S5-S10

2022

Link zum Volltext

Verfügbarkeit prüfen

Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary

Clinical infectious diseases, 2022-08, Vol.75 (Supplement_1), p.S46-S50

2022

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination

Vaccines (Basel), 2020-11, Vol.8 (4), p.663

2020

Link zum Volltext

Verfügbarkeit prüfen

Systems Biological Analysis of Immune Response to Influenza Vaccination

Cold Spring Harbor perspectives in biology, 2021-06, Vol.11 (6), p.1

2021

Link zum Volltext

Verfügbarkeit prüfen

Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)

Clinics in laboratory medicine, 2022-03, Vol.42 (1), p.111-128

2022

Link zum Volltext

Verfügbarkeit prüfen

Application of SARS-CoV-2 Serology to Address Public Health Priorities

Frontiers in public health, 2021-11, Vol.9, p.744535-744535

2021

Link zum Volltext

Verfügbarkeit prüfen

Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain

Science (American Association for the Advancement of Science), 2022-01, Vol.375 (6578), p.eabl6251-eabl6251

2022

Link zum Volltext

Verfügbarkeit prüfen

Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e920-e923

2022

Link zum Volltext

Verfügbarkeit prüfen

Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine

Vaccines (Basel), 2020-03, Vol.8 (1), p.126

2020

Link zum Volltext

Verfügbarkeit prüfen

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

Science translational medicine, 2022-01, Vol.14 (629), p.eabj5305

2022

Link zum Volltext

Verfügbarkeit prüfen

Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies

Expert review of vaccines, 2020-05, Vol.19 (5), p.455-463

2020

Link zum Volltext

Verfügbarkeit prüfen

Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM

Current HIV/AIDS reports, 2015-09, Vol.12 (3), p.353-361

2015

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors

Blood, 2023-07, Vol.142 (2), p.202

2023

Link zum Volltext

Verfügbarkeit prüfen

Precision Vaccines: Lessons Learned From the Coronavirus Pandemic

Clinical infectious diseases, 2022-08, Vol.75 (Supplement_1), p.S1-S1

2022

Link zum Volltext

Verfügbarkeit prüfen

Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study

Infection control and hospital epidemiology, 2022-11, Vol.43 (11), p.1664-1671

2022

Link zum Volltext

Verfügbarkeit prüfen

Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A cross-sectional analysis of subjects enrolled in the COVID-19 Prevention in Emory Healthcare Personnel (COPE) study

Infection control and hospital epidemiology, 2022-03, Vol.43 (3), p.381-386

2022

Link zum Volltext

Verfügbarkeit prüfen

Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility

Clinical biochemistry, 2023-07, Vol.117, p.60-68

2023

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients

Open forum infectious diseases, 2023-07, Vol.10 (7), p.ofad349-ofad349

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation

Transplantation and cellular therapy, 2023-05, Vol.29 (5), p.337.e1-337.e5

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva

The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States

SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System

Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients

The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients

Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic

Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary

The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination

Systems Biological Analysis of Immune Response to Influenza Vaccination

Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection)

Application of SARS-CoV-2 Serology to Address Public Health Priorities

Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain

Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity

Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine

An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice

Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies

Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM

Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adults

Precision Vaccines: Lessons Learned From the Coronavirus Pandemic

Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study

Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A cross-sectional analysis of subjects enrolled in the COVID-19 Prevention in Emory Healthcare Personnel (COPE) study

Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility

SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients

Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation

Suchergebnisse filtern